tiprankstipranks
Advertisement
Advertisement

EBR Systems Calls March Special Meeting to Approve Reverse Stock Split and Ratify Prior Placement

Story Highlights
  • EBR Systems will hold a March 2026 virtual special meeting to vote on a reverse stock split and ratification of a prior institutional placement.
  • The proposed consolidation will not alter total authorised share capital, CDI count or CDI price, but will change the CDI-to-share ratio as part of capital structure management.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EBR Systems Calls March Special Meeting to Approve Reverse Stock Split and Ratify Prior Placement

Claim 55% Off TipRanks

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) just unveiled an update.

EBR Systems will convene a virtual special meeting of stockholders in March 2026 to vote on key corporate actions, including a proposed amendment to its charter to implement a reverse stock split within a 1-for-5 to 1-for-20 range, and the ratification and approval of a prior institutional placement completed in May 2025. The company emphasised that the consolidation will not change its total authorised share capital, the number of issued CHESS Depositary Interests, or the CDI price, with the main mechanical impact being a change in the CDI-to-share transmutation ratio. Communication to securityholders about the meeting will be dispatched in late January, and management will host an investor webinar ahead of the vote to explain the strategic rationale for the share consolidation, underlining EBR Systems’ effort to manage its capital structure while maintaining access to both U.S. and Australian markets.

The most recent analyst rating on (AU:EBR) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

EBR Systems, Inc., based in Silicon Valley and listed on the ASX, operates in the medical device industry with a focus on cardiac rhythm disease. The company has developed its proprietary Wireless Stimulation Endocardially (WiSE) technology, the world’s only wireless, endocardial left ventricular pacing system in clinical use, designed to eliminate traditional cardiac pacing leads and associated complications. Its initial product targets heart failure patients requiring Cardiac Resynchronisation Therapy, with potential future applications in bradycardia and other non-cardiac indications.

Average Trading Volume: 556,713

Technical Sentiment Signal: Sell

Current Market Cap: A$474.7M

See more data about EBR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1